The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors.

[1]  P. Vitiello,et al.  Impact of tumor-derived CCL2 on T cell effector function. , 2004, Immunology letters.

[2]  J. Grosso,et al.  Up-Regulation of Matrix Metalloproteinase-9 in T Lymphocytes of Mammary Tumor Bearers: Role of Vascular Endothelial Growth Factor 1 , 2003, The Journal of Immunology.

[3]  H. Iwasaki,et al.  Monocyte Chemoattractant Protein-1 Selectively Inhibits the Acquisition of CD40 Ligand-Dependent IL-12-Producing Capacity of Monocyte-Derived Dendritic Cells and Modulates Th1 Immune Response1 , 2002, The Journal of Immunology.

[4]  A. Zlotnik,et al.  Chemokines: agents for the immunotherapy of cancer? , 2002, Nature Reviews Immunology.

[5]  S. Vogel,et al.  Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. , 2001, Cytokine.

[6]  M. Herlyn,et al.  Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.

[7]  L. Boise,et al.  CD30 Signals Integrate Expression of Cytotoxic Effector Molecules, Lymphocyte Trafficking Signals, and Signals for Proliferation and Apoptosis1 , 2000, The Journal of Immunology.

[8]  J. Ward,et al.  Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.

[9]  M. Loda,et al.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 , 2000, Nature.

[10]  B. Kelsall,et al.  Selective Suppression of IL-12 Production by Chemoattractants , 2000, The Journal of Immunology.

[11]  C. Bucana,et al.  Induction of Chemokine Secretion and Enhancement of Contact-Dependent Macrophage Cytotoxicity by Engineered Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Human Colon Cancer Cells1 , 2000, The Journal of Immunology.

[12]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[13]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[14]  D. Lopez,et al.  Elevated GM-CSF levels in tumor bearing mice upregulate IL-6 production by B cells via a mechanism independent of TNF-alpha. , 2000, International journal of oncology.

[15]  H. Drexler,et al.  Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli. , 1999, Leukemia research.

[16]  G. Heinze,et al.  Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients , 1999, British Journal of Cancer.

[17]  H. Augustin,et al.  Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1 , 1999, International journal of cancer.

[18]  G. Opdenakker,et al.  The MCP/eotaxin subfamily of CC chemokines. , 1999, Cytokine & growth factor reviews.

[19]  M. Perretti,et al.  Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. , 1999, Journal of immunology.

[20]  W. Schultze‐Seemann,et al.  Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. , 1998, British journal of urology.

[21]  C. Brosnan,et al.  MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study , 1998, Journal of Neuroimmunology.

[22]  X. Cheng,et al.  CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine. , 1998, Journal of immunology.

[23]  N. Jonjić,et al.  Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. , 1998, Pathology, research and practice.

[24]  D. Lopez,et al.  Altered binding of the NF-GMa transcription factor is involved in the upregulated production of TNF-alpha by macrophages of mammary tumor bearing mice. , 1998, International journal of molecular medicine.

[25]  A. Lazzarin,et al.  Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. , 1998, Blood.

[26]  J. Krauss,et al.  Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells. , 1997, Cancer research.

[27]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[28]  X. Cheng,et al.  Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor-derived factors. , 1996, Anticancer research.

[29]  Y. Aramaki,et al.  Inhibitory effects of negatively charged liposomes on nitric oxide production from macrophages stimulated by LPS. , 1996, Biochemical and biophysical research communications.

[30]  G. Stamp,et al.  The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. , 1995, The Journal of clinical investigation.

[31]  F. Herrmann,et al.  Regulation of MCP-1/JE gene expression during monocytic differentiation. , 1994, Journal of immunology.

[32]  P. Allavena,et al.  Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3 , 1994, European journal of immunology.

[33]  A. Mantovani,et al.  Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. , 1994, Journal of immunology.

[34]  Diana,et al.  Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine , 1994, The Journal of experimental medicine.

[35]  G. Opdenakker,et al.  Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. , 1994, Journal of immunology.

[36]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Podack,et al.  Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets. , 1994, Journal of immunology.

[38]  A. Ho,et al.  Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes , 1994 .

[39]  A. Sousa,et al.  Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. , 1994, American journal of respiratory cell and molecular biology.

[40]  J. Kuratsu,et al.  Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. , 1993, Journal of the National Cancer Institute.

[41]  M. Burdick,et al.  Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. , 1992, The Journal of clinical investigation.

[42]  P. Kuna,et al.  Monocyte chemotactic and activating factor is a potent histamine- releasing factor for human basophils , 1992, The Journal of experimental medicine.

[43]  D. Graves,et al.  Expression of monocyte chemotactic protein-1 in human melanoma in vivo. , 1992, The American journal of pathology.

[44]  G. Remuzzi,et al.  Interleukin-1β and tumor necrosis factor-α induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells , 1991 .

[45]  E. Sotomayor,et al.  Modulation of the immune system by mammary tumor-derived factors. , 1991, Cancer investigation.

[46]  K. Arai,et al.  Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. J. Valente,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Jimenez,et al.  Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. , 1990, Cancer research.

[49]  S. Rosenberg,et al.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. , 1989, Journal of immunology.

[50]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .

[51]  D. Santoli,et al.  Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor. , 1988, Journal of immunology.

[52]  M. Haine,et al.  Van Damme A. , 1986 .

[53]  M. Meltzer,et al.  Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. , 1985, Journal of immunology.

[54]  A. Miller,et al.  Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocaricinoma. i. characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity , 1984, International journal of cancer.

[55]  Elizabeth Simpson,et al.  A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.

[56]  D. Medina,et al.  Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination. , 1969, Journal of the National Cancer Institute.